Inorganic nanoparticles for enhanced photodynamic cancer therapy

Current Drug Discovery Technologies

Volumn 8, Issue 3, 2011, Pages 269-276

  Cheng, Shih Hsun ^a,b   Lo, Leu Wei ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Nanodelivery; Photodynamic therapy (PDT); Photosensitizer (PS)

Indexed keywords

NANOPARTICLE; PHOTOSENSITIZING AGENT; SINGLET OXYGEN;

ARTICLE; BIOCOMPATIBILITY; CANCER THERAPY; DOSIMETRY; DRUG FORMULATION; HUMAN; NANOPHARMACEUTICS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 80051965472     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016311796798982     Document Type: Article

References (60)

1. Robertson CA, Evans DH, Abrahamse H. Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 2009;96(1):1-8.
2. Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist 2006;11(9):1034-44. (Pubitemid 44564813)
3. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90(12):889-905. (Pubitemid 28304157)
4. Taquet JP, Frochot C, Manneville V, Barberi-Heyob M. Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Curr Med Chem 2007;14(15):1673-87. (Pubitemid 47010155)
5. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008;60(15):1627-37.
6. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008;26(11):612-21.
7. Hoffman AS. The origins and evolution of "controlled" drug delivery systems. J Controlled Release 2008;132(3):153-63.
8. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28(1):5-24. (Pubitemid 27497671)
9. Konan YN, Berton M, Gurny R, Allémann E. Enhanced photodynamic activity of meso-tetra (4-hydroxyphenyl) porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci 2003;18(3-4):241-9. (Pubitemid 36349275)
10. McCarthy JR, Perez JM, Brückner C, Weissleder R. Polymeric nanoparticle preparation that eradicates tumors. Nano Lett 2005;5(12):2552-6. (Pubitemid 43088911)
11. Couleaud P, Morosini V, Frochot C, Richeter S, Raehm L, Durand JO. Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2010;2(7):1083-95.
12. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26(18):3995-4021. (Pubitemid 40044762)
13. Chen J, Wang D, Xi J, et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 2007;7(5):1318-22. (Pubitemid 46834416)
14. Diagaradjane P, Shetty A, Wang JC, et al. Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascularfocused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy. Nano Lett 2008;8(5):1492-500.
15. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128(6):2115-20. (Pubitemid 43277351)
16. Schmidt ME, Blanton SA, Hines MA, Guyot-Sionnest P. Sizedependent two-photon excitation spectroscopy of CdSe nanocrystals. Phys Rev B 1996;53:12629-36.
17. Larson DR, Zipfel WR, Williams RM, et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 2003;300(5624):1434-6. (Pubitemid 36638163)
18. Hone DC, Walker PI, Evans-Gowing R, et al. Generation of cytotoxic singlet Oxygen via phthalocyanine-stabilized gold Nanoparticles: A potential delivery vehicle for photodynamic therapy. Langmuir 2002;18(8):2985-7. (Pubitemid 35383751)
19. Cheng Y, C Samia A, Meyers JD, Panagopoulos I, Fei B, Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 2008;130(32):10643-7.
20. Kuo WS, Chang CN, Chang YT, Yeh CS. Antimicrobial gold nanorods with dual-modality photodynamic inactivation and hyperthermia. Chem Commun 2009;32:4853-5.
21. Kuo WS, Chang CN, Chang YT, et al. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angew. Chem Int Ed 2010;49:2711-5.
22. Záruba K, Králová J, Rezanka P, Poucková P, Veverková L, Král V. Modified porphyrin-brucine conjugated to gold nanoparticles and their application in photodynamic therapy. Org Biomol Chem 2010;8(14):3202-6.
23. Zhao T, Wu H, Yao SQ, Xu QH, Xu GQ. Nanocomposites containing gold nanorods and porphyrin-doped mesoporous silica with dual capability of two-photon imaging and photosensitization. Langmuir 2010;26(18):14937-42.
24. Kopelman R, Koo YEL, Philbert M, et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J Magn Magn Mater 2005;293(1):404-10. (Pubitemid 40608959)
25. Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006;12(22):6677-86. (Pubitemid 44876835)
26. McCarthy JR, Jaffer FA, Weissleder R. A macrophage-targeted theranostic nanoparticle for biomedical applications. Small 2006;2(8-9):983-7. (Pubitemid 44230996)
27. McCarthy JR, Korngold E, Weissleder R, Jaffer FA: A lightactivated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis. Small 2010;6(18):2041-9.
28. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006;3(4):415-23. (Pubitemid 44351924)
29. Tada DB, Vono LLR, Duarte EL, et al. Methylene blue-containing silica-coated magnetic particles: A potential magnetic carrier for photodynamic therapy. Langmuir 2007;23(15):8194-9. (Pubitemid 47155335)
30. Chen ZL, Sun Y, Huang P, Yang XX, Zhou XP. Studies on preparation of photosensitizer loaded magnetic silica nanoparticles and their anti-tumor effects for targeting photodynamic therapy. Nanoscale Res Lett 2009;4(5):400-8.
31. Liu F, Zhou X, Ni S, Wang X, Yong Z, Chen Z. Preparation and properties of photosensitizer loaded magnetic nanocarriers. Curr Nanosci 2009;5(4):293-6.
32. Lai CW, Wang YH, Lai CH, et al. Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008;4(2):218-24.
33. Yan F, Kopelman R. The embedding of meta-tetra (hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties. Photochem Photobiol 2003;78(6):587-91.
34. Tang W, Xu H. Kopelman R, Philbert MA. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol 2005;81(2):242-9. (Pubitemid 40551499)
35. Roy I, Ohulchanskyy TY, Pudavar HE, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 2003;125(26):7860-5. (Pubitemid 36782161)
36. Ohulchanskyy TY, Roy I, Goswami LN, et al. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett 2007;7(9):2835-42. (Pubitemid 47522446)
37. Kim S, Ohulchanskyy TY, Bharali D, Chen YH, Pandey RK, Prasad PN. Organically modified silica nanoparticles with intraparticle heavy-atom effect on the encapsulated photosensitizer for enhanced efficacy of photodynamic therapy. J Phys Chem C 2009;113(29):12641-4.
38. Zhao B, Yin JJ, Bilski PJ, Chignell CF, Roberts JE, He YY. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol Appl Pharmacol 2009:241(2):163-72.
39. Simon V, Devaux C, Darmon A, et al. Pp IX silica nanoparticles demonstrate differential interactions with in vitro tumor cell lines and in vivo mouse models of human cancers. Photochem Photobiol 2010;86(1):213-22.
40. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem, Int. Ed., 2007;46:7548-58. (Pubitemid 47556998)
41. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Delivery Rev 2008;60(11):1278-88.
42. Tu HL, Lin YS, Hung Y, Lo LW, Chen YF, Mou CY. In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater 2009;21:172-4.
43. Cheng SH, Lee CH, Yang CS, Tseng FG, Mou CY, Lo LW. Mesoporous silica nanoparticles functionalized with an oxygensensing probe for cell photodynamic therapy: potential cancer theranostics. J Mater Chem 2009;19:1252-7.
44. Brevet D, Gary-Bobo M, Raehm L, et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 2009;1475-7.
45. Cheng SH, Lee CH, Chen MC. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy. J Mater Chem 2010;20:6149-57.
46. Zhang R, Wu C, Tong L, Tang B, Xu QH. Multifunctional coreshell nanoparticles as highly efficient imaging and photosensitizing agents. Langmuir 2009;25(17):10153-8.
47. Kim HJ, Shin KJ, Han MK, et al. One-pot synthesis of multifunctional mesoporous silica nanoparticle incorporated with zinc (II) phthalocyanine and iron oxide. Scr Mater 2009;61:1137-40.
48. Chen W., Zhang J.: Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol 2006;6:1159-66. (Pubitemid 44578047)
49. Chen W. Nanoparticle Self-Lighting Photodynamic Therapy for Cancer Treatment. J Biomed Nanotechnol 2008;4(4):369-76.
50. Liu YF, Chen W, Wang SP, Joly AG. Investigation of watersoluble X-ray luminescence nanoparticles for photodynamic activation. Appl Phys Lett 2008;92:043901.
51. Wang F, Banerjee D, Liu Y, Chen X, Liu X. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010;135:1839-54.
52. Chatterjee DK, Gnanasammandhan MK, Zhang Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 2010;6(24):2781-95.
53. Zhang P, Steelant W, Kumar M, Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc 2007;129(15):4526-7. (Pubitemid 46648745)
54. Chatterjee DK, Zhang Y. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine 2008;3(1):73-82. (Pubitemid 351611866)
55. Qian HS, Guo HC, Ho PC, Mahendran R, Zhang Y. Mesoporoussilica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small 2009;5(20):2285-90.
56. Gao D, Agayan RR, Xu H, Philbert MA, Kopelman R. Nanoparticles for Two-Photon Photodynamic Therapy in Living Cells. Nano Lett 2006;6(11):2383-6. (Pubitemid 46076922)
57. Velusamy M, Shen JY, Lin JT. A new series of quadrupolar type two-photon absorption chromophores bearing 11, 12-dibutoxydibenzo [a, c]-phenazine bridged amines; their Applications in two-photon fluorescence imaging and two-photon photodynamic therapy. Adv Funct Mater 2009;19(15):2388-97.
58. Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J Am Chem Soc 2007;129(9):2669-75. (Pubitemid 46364075)
59. Dayal S, Burda C. Semiconductor Quantum Dots as Two-Photon Sensitizers. J Am Chem Soc 2008;130(10):2890-1. (Pubitemid 351455932)
60. Wen YN, Song WS, An LM, Liu YQ, Wang YH, Yang YQ. Activation of porphyrin photosensitizers by semiconductor quantum dots via two-photon excitation. Appl Phys Lett 2009;95:143702.